Today’s Stocks to Watch: Walmart, Nvidia, and Tesla

Published:

- Advertisement -

Key Points To Watch Out For:

  • Walmart shares fall following direct criticism from Trump.
  • Nvidia drops despite new partnership plan with Taiwanese partners.
  • UnitedHealth climbs after eight consecutive sessions in the red.

Walmart (WMT): Political Pressure Hits Retail Giant

Walmart shares fell in premarket trading after President Trump criticized the company for blaming tariffs for recent price increases. In a statement on Saturday, Trump called on the retailer to “absorb the cost” of tariffs instead of passing it on to consumers. The public rebuke has created uncertainty among investors and revived concerns over consumer stock margins.

Nvidia (NVDA): New Strategic Alliance with Taiwanese Partners

Nvidia announced plans to strengthen its partnerships in Taiwan, including a notable agreement with Foxconn to build an artificial intelligence supercomputer. Despite the announcement, shares fell in premarket trading, reflecting a broader sell-off in the tech sector. Nvidia remains a key bellwether for AI-related equities, though recent market volatility has weighed on its performance.

Tesla (TSLA), Palantir (PLTR), and MicroStrategy (MSTR): Retail Favorites Under Pressure

Several high-profile stocks popular among retail investors fell before the open, including Tesla, Palantir, and MicroStrategy. The pullback appears linked to renewed caution in the broader market and rising concerns about the macroeconomic environment, including potential new trade barriers. These companies—closely tied to technology or crypto assets—remain especially vulnerable to shifts in market sentiment.

UnitedHealth (UNH): Technical Rebound Amid Legal Scrutiny

UnitedHealth rose in premarket trading, extending its recovery from Friday after eight straight sessions of losses. The rebound appears to be driven by tactical buying, even as the company faces a Justice Department investigation into possible Medicare fraud. Healthcare stocks remain highly sensitive to regulatory and legal developments.

Related articles